您好,欢迎来到易推广 请登录 免费注册

上海陶术生物科技有限公司 主营产品:生物试剂,实验服务等

当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示

企业档案

会员类型:会员

已获得易推广信誉   等级评定
139成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

易推广会员:5

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

企业类型:生产商 【已认证】

注册资金:人民币万 【已认证】

产品数:86101

参观次数:3553022

手机网站:http://m.yituig.com/c135739/

旗舰版地址:http://tsbiochem.app17.com

自主品牌

已选条件

  • T3550X-376X-396;Ensartinib;恩沙替尼

    Ensartinib (X-396) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inhibits ALK kinase, ALK fusion protei

    价 格:¥电议型 号:T3550产 地:中国大陆

  • T22324Ensartinib hydrochlorideEnsartinib dihydrochloride;X-396 dihydrochloride

    Ensartinib dihydrochloride is a potent new-generation ALK inhibitor with high activity against CNS metastases and a broad range of known crizotinib-resistant ALK mutations. It potently inhibits both wild-type ALK and ALK variants (C1156Y, F1174, G1202R, L

    价 格:¥电议型 号:T22324产 地:中国大陆

  • T37585Ensartinib;Ensartinib (X-396)Ensartinib

    Ensartinib (X-396) is a potent and dual ALK/MET inhibitor with IC50s of <0.4 nM and 0.74 nM, respectively.

    价 格:¥电议型 号:T37585产 地:中国大陆

  • T3550X-376;恩沙替尼Ensartinib|||X-396;Ensartinib|||X-396|||恩沙替尼

    X-376 (Ensartinib) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inhibits ALK kinase, ALK fusion proteins, and ALK point mutation variants. Inhibition of ALK leads to the disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-expressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an import

    价 格:¥电议型 号:T3550产 地:中国大陆

  • T22324Ensartinib hydrochloride;化合物Ensartinib (X-396) dihydrochlorideEnsartinib dihydrochloride|||X-396 dih

    Ensartinib hydrochloride (X-396 dihydrochloride) is a potent new-generation ALK inhibitor with high activity against CNS metastases and a broad range of known crizotinib-resistant ALK mutations. It potently inhibits both wild-type ALK and ALK variants (C1156Y, F1174, G1202R, L1196M, S1206R, and T1151 mutants) with in vitro IC50s of <4 nM.

    价 格:¥电议型 号:T22324产 地:中国大陆

1共1页

快速导航

在线咨询

提交